Michigan Ear Institute, Farmington Hills, MI.
Department of Surgery, University of Alabama, Birmingham, AL.
Ann Surg. 2019 Jul;270(1):69-76. doi: 10.1097/SLA.0000000000003130.
This review details the agents for fluorescence-guided nerve imaging in both preclinical and clinical use to identify factors important in selecting nerve-specific fluorescent agents for surgical procedures.
Iatrogenic nerve injury remains a significant cause of morbidity in patients undergoing surgical procedures. Current real-time identification of nerves during surgery involves neurophysiologic nerve stimulation, which has practical limitations. Intraoperative fluorescence-guided imaging provides a complimentary means of differentiating tissue types and pathology. Recent advances in fluorescence-guided nerve imaging have shown promise, but the ideal agent remains elusive.
In February 2018, PubMed was searched for articles investigating peripheral nerve fluorescence. Key terms used in this search include: "intraoperative, nerve, fluorescence, peripheral nerve, visualization, near infrared, and myelin." Limits were set to exclude articles exclusively dealing with central nervous system targets or written in languages other than English. References were cross-checked for articles not otherwise identified.
Of the nonspecific agents, tracers that rely on axonal transport showed the greatest tissue specificity; however, neurovascular dyes already enjoy wide clinical use. Fluorophores specific to nerve moieties result in excellent nerve to background ratios. Although noteworthy findings on tissue specificity, toxicity, and route of administration specific to each fluorescent agent were reported, significant data objectively quantifying nerve-specific fluorescence and toxicity are lacking.
Fluorescence-based nerve enhancement has advanced rapidly over the past 10 years with potential for continued utilization and progression in translational research. An ideal agent would be easily administered perioperatively, would not cross the blood-brain barrier, and would fluoresce in the near-infrared spectrum. Agents administered systemically that target nerve-specific moieties have shown the greatest promise. Based on the heterogeneity of published studies and methods for reporting outcomes, it appears that the development of an optimal nerve imaging agent remains challenging.
本综述详细介绍了荧光引导神经成像在临床前和临床应用中的试剂,以确定选择用于手术的神经特异性荧光试剂的重要因素。
医源性神经损伤仍然是接受手术治疗的患者发病率的一个重要原因。目前术中实时识别神经涉及神经生理神经刺激,其具有实际限制。术中荧光引导成像提供了区分组织类型和病理的补充手段。最近荧光引导神经成像的进展显示出了希望,但理想的试剂仍然难以捉摸。
2018 年 2 月,在 PubMed 上搜索了外周神经荧光的研究文章。该搜索中使用的关键词包括:“术中、神经、荧光、周围神经、可视化、近红外和髓鞘”。限制条件排除了专门涉及中枢神经系统靶点或用英语以外的语言书写的文章。交叉检查了参考文献以确定其他未识别的文章。
在非特异性试剂中,依赖轴突运输的示踪剂显示出最大的组织特异性;然而,神经血管染料已经广泛应用于临床。针对神经结构的荧光团产生极佳的神经与背景比。尽管报告了与每种荧光试剂的组织特异性、毒性和给药途径相关的显著发现,但缺乏客观定量神经特异性荧光和毒性的数据。
基于荧光的神经增强在过去 10 年中发展迅速,具有持续利用和转化研究进展的潜力。理想的试剂将在围手术期易于管理,不会穿过血脑屏障,并在近红外光谱中发光。靶向神经特异性结构的系统给药试剂显示出最大的希望。基于发表研究的异质性和报告结果的方法,似乎开发最佳神经成像试剂仍然具有挑战性。